Pacira Biosciences: Leerink Partners raises target price to $36.5 from $28
PCRX•Leerink Partners raised its target price for Pacira Biosciences to $36.5 from $28.
Related News
Centene to redeem $568.66 million of 4.25% notes due 2027 on Oct. 23, 2026
CNC•
Nasdaq halts trading in INHD for volatility pause at 10:20 a.m.
INHD•
LoanCare launches IllumineX AI platform to boost borrower engagement, servicing performance
FNF•
Nasdaq halts trading in ALISU for volatility at 10:43 a.m.
ALISU•
North Carolina reports first flu death of 2026-27 season
XLV•